![Ivan Bergstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Bergstein
Director Ejecutivo en
STEMLINE THERAPEUTICS, INC.
.
Perfil
Dr. Ivan Bergstein, MD, is a President & Chief Executive Officer at Stemline Therapeutics, Inc.
Dr. Bergstein was previously employed as a Chairman by Lirum Therapeutics, Inc., a Medical Director by ACCESS Oncology, Inc., a Medical Director by Keryx Biopharmaceuticals, Inc., and a Senior Biopharmaceuticals Analyst by Nitron Advisors.
He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Cargos activos de Ivan Bergstein
| Empresas | Cargo | Inicio |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Director Ejecutivo | - |
Antiguos cargos conocidos de Ivan Bergstein.
| Empresas | Cargo | Fin |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Presidente | - |
Nitron Advisors
 Nitron Advisors Investment ManagersFinance Operates investment research company | Corporate Officer/Principal | - |
| KERYX BIOPHARMACEUTICALS | Director Técnico/Científico/I+D | - |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Director Técnico/Científico/I+D | - |
Formación de Ivan Bergstein.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
24
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Operates investment research company | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that focuses on the treatment of debilitating diseases | Commercial Services |
- Bolsa de valores
- Insiders
- Ivan Bergstein
